leucovorin calcium / Generic mfg. 
Welcome,         Profile    Billing    Logout  
 424 Diseases   807 Trials   807 Trials   14372 News 


«12...204205206207208209210211212213214...235236»
  • ||||||||||  Zolinza (vorinostat) / Merck (MSD), Decadron (dexamethasone) / Merck (MSD), Oncaspar liquid (pegaspargase) / Servier
    Enrollment open:  Total Therapy for Infants With Acute Lymphoblastic Leukemia (ALL) I (clinicaltrials.gov) -  Oct 22, 2015   
    P2,  N=50, Recruiting, 
    Not yet recruiting --> Recruiting
  • ||||||||||  Avastin (bevacizumab) / Roche, Erbitux (cetuximab) / Eli Lilly
    Enrollment change, Trial termination, Trial primary completion date, Metastases:  Lohp, 5-Fu/Lv and Bevacizumab, Alternative With Cpt-11, 5-Fu/Lv and Cetuximab In Metastatic Crc (clinicaltrials.gov) -  Oct 7, 2015   
    P2,  N=24, Terminated, 
    Active, not recruiting --> Completed N=50 --> 24 | Recruiting --> Terminated | Trial primary completion date: Dec 2012 --> Aug 2012; Due to poor Accrual
  • ||||||||||  dilpacimab (ABT-165) / AbbVie
    Trial primary completion date, Metastases:  A Study of ABT-165 in Subjects With Solid Tumors (clinicaltrials.gov) -  Oct 1, 2015   
    P1,  N=100, Recruiting, 
    Trial primary completion date: Nov 2015 --> Nov 2016 Trial primary completion date: Jul 2015 --> Aug 2016
  • ||||||||||  Biomarker, Trial primary completion date, MSi-H Biomarker, PD(L)-1 Biomarker:  MODUL: A Study of Biomarker-Driven Therapy in Metastatic Colorectal Cancer (mCRC) (clinicaltrials.gov) -  Sep 24, 2015   
    P2,  N=610, Recruiting, 
    Initiation date: Apr 2015 --> Nov 2015 | Trial primary completion date: Apr 2017 --> Nov 2017 Trial primary completion date: Mar 2019 --> Dec 2018
  • ||||||||||  TheraSphere (yttrium 90 microspheres) / Boston Scientific
    Trial primary completion date:  Phase II Trial Evaluating OS With Therasphere (clinicaltrials.gov) -  Sep 24, 2015   
    P2,  N=9, Active, not recruiting, 
    Trial primary completion date: Oct 2017 --> Apr 2018 Trial primary completion date: Dec 2015 --> Apr 2016
  • ||||||||||  Erbitux (cetuximab) / Eli Lilly
    Enrollment change, Trial termination, Trial primary completion date:  Treatment Regimens for Patients With Resectable Liver Metastases (PANTER Study) (clinicaltrials.gov) -  Sep 22, 2015   
    P=N/A,  N=16, Terminated, 
    Not yet recruiting --> Recruiting N=430 --> 16 | Active, not recruiting --> Terminated | Trial primary completion date: May 2015 --> Sep 2015; Recruitment difficulities
  • ||||||||||  Zolinza (vorinostat) / Merck (MSD), Decadron (dexamethasone) / Merck (MSD), Oncaspar liquid (pegaspargase) / Servier
    New P2 trial:  Total Therapy for Infants With Acute Lymphoblastic Leukemia (ALL) I (clinicaltrials.gov) -  Sep 17, 2015   
    P2,  N=50, Not yet recruiting,